Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $13.00 at Lake Street Capital

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective cut by analysts at Lake Street Capital from $25.00 to $13.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s price objective suggests a potential upside of 50.29% from the company’s current price.

BIOX has been the topic of several other reports. Canaccord Genuity Group reiterated a “buy” rating and set a $17.00 price target on shares of Bioceres Crop Solutions in a report on Friday, July 19th. Roth Capital raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Roth Mkm began coverage on Bioceres Crop Solutions in a research report on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 price objective on the stock. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $15.25.

Bioceres Crop Solutions Trading Down 13.4 %

Shares of BIOX stock opened at $8.65 on Wednesday. The company has a market cap of $543.22 million, a PE ratio of 865.00 and a beta of 0.49. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.22 and a quick ratio of 0.83. The stock’s 50 day simple moving average is $10.59 and its two-hundred day simple moving average is $11.50. Bioceres Crop Solutions has a 1 year low of $8.42 and a 1 year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The company had revenue of $124.30 million during the quarter, compared to the consensus estimate of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Research analysts predict that Bioceres Crop Solutions will post 0.3 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Activest Wealth Management bought a new position in shares of Bioceres Crop Solutions during the 1st quarter worth $30,000. Cape Investment Advisory Inc. bought a new position in Bioceres Crop Solutions during the 4th quarter worth about $33,000. Oppenheimer & Co. Inc. purchased a new position in Bioceres Crop Solutions during the 1st quarter valued at about $139,000. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at about $212,000. Finally, Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions in the 2nd quarter worth approximately $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.